411 related articles for article (PubMed ID: 8141836)
1. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
Mackness MI; Arrol S; Abbott C; Durrington PN
Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein.
Mackness MI; Arrol S; Durrington PN
FEBS Lett; 1991 Jul; 286(1-2):152-4. PubMed ID: 1650712
[TBL] [Abstract][Full Text] [Related]
3. Lack of protection against oxidative modification of LDL by avian HDL.
Mackness B; Durrington PN; Mackness MI
Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
Graham A; Hassall DG; Rafique S; Owen JS
Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
[TBL] [Abstract][Full Text] [Related]
7. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.
Cao H; Girard-Globa A; Berthezene F; Moulin P
J Lipid Res; 1999 Jan; 40(1):133-9. PubMed ID: 9869659
[TBL] [Abstract][Full Text] [Related]
9. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.
Mackness MI; Abbott C; Arrol S; Durrington PN
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):829-34. PubMed ID: 8379937
[TBL] [Abstract][Full Text] [Related]
10. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
11. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
[TBL] [Abstract][Full Text] [Related]
13. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat.
Sutherland WH; Walker RJ; de Jong SA; van Rij AM; Phillips V; Walker HL
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1340-7. PubMed ID: 10323788
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
[TBL] [Abstract][Full Text] [Related]
15. Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation.
Fuhrman B; Aviram M
Ann N Y Acad Sci; 2002 May; 957():321-4. PubMed ID: 12074989
[TBL] [Abstract][Full Text] [Related]
16. The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.
Sangvanich P; Mackness B; Gaskell SJ; Durrington P; Mackness M
Biochem Biophys Res Commun; 2003 Jan; 300(2):501-6. PubMed ID: 12504112
[TBL] [Abstract][Full Text] [Related]
17. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R.
Aviram M; Billecke S; Sorenson R; Bisgaier C; Newton R; Rosenblat M; Erogul J; Hsu C; Dunlop C; La Du B
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1617-24. PubMed ID: 9763535
[TBL] [Abstract][Full Text] [Related]
19. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
